Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPulsar Helium Regulatory News (PLSR)

Share Price Information for Pulsar Helium (PLSR)

Share Price is delayed by 15 minutes
Get Live Data
85.00    1.00 (1.19%)
Bid:
83.40
Ask:
85.00
Spread: 1.60 (1.918%)
Market Cap: £159.16m
PLSR Live PriceLast checked at - London Stock Exchange

Intraday Pulsar Helium Share Chart

Oscillate Update, Warrant Exercise & TVR

9 Mar 2026 07:00

RNS Number : 7545V
Pulsar Helium Inc.
09 March 2026
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS.

NEWS RELEASE | MARCH 9, 2026 | CASCAIS, PORTUGAL

PULSAR HELIUM PROVIDES UPDATE ON TRANSACTION WITH OSCILLATE PLC, WARRANT EXERCISE AND TVR

Pulsar Helium Inc. (AIM: PLSR, TSXV: PLSR, OTCQB: PSRHF) ("Pulsar" or the "Company"), a primary helium company, provides an update following its announcements on November 4, 2025, December 19, 2025, January 21, 2026, and February 10, 2026, regarding its option to acquire up to 100% of the shares of Quantum Hydrogen Inc. ("Quantum"), a 100% owned subsidiary of Oscillate PLC ("Oscillate"), in an all-share transaction (the "Transaction").

On December 18, 2025, the Company issued a total of 292,560 common shares (the "Consideration Shares") to Oscillate, satisfying the first and second monthly share option tranches valued at US$80,000 each, at a VWAP of C$0.7797 for tranche one and C$0.7543 for tranche two.

On January 20, 2026, the Company issued an additional 145,434 Consideration Shares to Oscillate, satisfying the third monthly share option tranche of US$80,000 at a VWAP of C$0.7556.

On February 9, 2026, the Company issued an additional 80,947 Consideration Shares to Oscillate, satisfying the fourth monthly share option tranche of US$80,000 at a VWAP of C$1.3508.

On March 6, 2026, the Company issued an additional 66,022 Consideration Shares to Oscillate, satisfying the fifth and final monthly share option tranche of US$80,000 at a VWAP of C$1.6581.

Under the terms of the agreement with Oscillate, the Company has now acquired 80% of the shares of Quantum upon having issued to Oscillate all of the required monthly tranches of Consideration Shares. The Company also has the option until May 3, 2027, to acquire the remaining 20% of the shares of Quantum from Oscillate in exchange for US$400,000 of Consideration Shares to be issued in 5 instalments of US$80,000 of Consideration Shares each after the Company has provided notice to Oscillate that it wishes to exercise such option. The Company will evaluate this option in coming months, and prior to the May 3, 2027, deadline date.

The Consideration Shares issued in connection with the Transaction are subject to a four-month-and-one-day hold period from the date of issuance.

Warrant Exercise

In addition, the Company notes that on March 6, 2026, 500,000 share purchase warrants ("Warrant Exercise Shares") - issued as part of its offering that closed on October 14, 2024 - were exercised at a price of £0.25 per share, generating cash proceeds for the Company of £125,000.

Admission to AIM and Total Voting Rights

Application is being made to the London Stock Exchange plc for the admission of the 500,000 Warrant Exercise Shares to be admitted to trading on AIM, which is expected to occur and dealings commence at 8:00 a.m. on or around March 10, 2026 ("First Admission"). Application is also being made to the London Stock Exchange plc for the admission of the 66,022 Consideration Shares to be admitted to trading on AIM, which is expected to occur, and dealings commence at 8:00 a.m. on or around March 12, 2026 ("Second Admission").

The new common shares will rank pari passu with the Company's existing common shares.

On First Admission, the total number of common shares in issue will be 180,642,697 with voting rights. On Second Admission, the total number of common shares in issue will be 180,708,719 with voting rights. These figures may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's issued share capital pursuant to the Company's Articles.

On behalf of Pulsar Helium Inc.

"Thomas Abraham-James"

President, CEO and Director

Further Information:

Pulsar Helium Inc.

connect@pulsarhelium.com

+ 1 (218) 203-5301 (USA/Canada)

+44 (0) 2033 55 9889 (United Kingdom)

https://pulsarhelium.com

https://ca.linkedin.com/company/pulsar-helium-inc

Strand Hanson Limited

(Nominated & Financial Adviser, and Broker)

Ritchie Balmer / Rob Patrick / Richard Johnson

+44 (0) 207 409 3494

Yellow Jersey PR Limited

(Financial PR)

Charles Goodwin / Annabelle Wills

+44 777 5194 357

pulsarhelium@yellowjerseypr.com

About Pulsar Helium Inc.

Pulsar Helium Inc. is a publicly traded company quoted on the AIM market of the London Stock Exchange and listed on the TSX Venture Exchange with the ticker PLSR, as well as on the OTCQB with the ticker PSRHF. Pulsar's portfolio consists of its flagship Topaz helium project in Minnesota, USA, and the Tunu helium project in Greenland. Pulsar is the first mover in both locations with primary helium occurrences not associated with the production of hydrocarbons identified at each.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUGUWUPQGRQ
Date   Source Headline
23rd Dec 20256:00 pmRNSOption Exercise and TVR
19th Dec 20257:00 amRNSCloses Major Minnesota Land Position and TVR
19th Dec 20257:00 amRNSCloses Major Minnesota Land Position and TVR
17th Dec 20257:00 amRNSPulsar Awards Security Based Compensation
8th Dec 20257:00 amRNSPressurised Gas Encounter Jetstream #5
3rd Dec 20257:00 amRNSPulsar Helium Commences Drilling of Jetstream #5
26th Nov 20257:00 amRNSAppoint Cliff Cain Announce Completion Jetstream 4
18th Nov 20257:00 amRNSPressurised Gas Encounter at Jetstream #4
17th Nov 20257:00 amRNS-RPulsar to host Virtual Site Visit and Q&A with CEO
11th Nov 20257:00 amRNSAppraisal Programme Completed Jetstream 3
7th Nov 20257:00 amRNSStock Option Exercise and TVR
6th Nov 20257:00 amRNSWarrant Exercise by Major Investor Proceeds C$5.6M
4th Nov 20257:00 amRNSDefinitive Agreement to Acquire Land Position
30th Oct 20257:00 amRNSJetstream #3 Encounters Gas Near-1000 PSI
28th Oct 20257:00 amRNSDirector/PDMR Shareholding
27th Oct 20257:00 amRNSProposed Acquisition Michigan Helium Assets
23rd Oct 20254:53 pmRNSWarrant Exercise and TVR
23rd Oct 20257:00 amRNSAppoints Dr. Peter Barry as Helium-3 Advisor
22nd Oct 20254:58 pmRNSStock Option Exercise and TVR
20th Oct 20257:00 amRNSWarrant Exercise and TVR
16th Oct 20257:15 amRNSWarrant and Stock Option Exercise and TVR
16th Oct 20257:00 amRNSFiling of Preliminary Short Form Base Shelf
14th Oct 20257:00 amRNSMobilizes Drill Rig and Ancillary Equipment Topaz
13th Oct 20257:00 amRNSStock Option Exercise and TVR
8th Oct 20257:00 amRNSWarrant Exercise and TVR
3rd Oct 20257:00 amRNSStock Option Exercise and TVR
1st Oct 20251:43 pmRNSCorrection - Helium-3 Discovery at Jetstream#1
1st Oct 20257:00 amRNSHelium-3 Discovery at Jetstream#1, Topaz Project
29th Sep 20257:00 amRNSPromising Pre-Feasibility Results for Tunu Project
19th Sep 20257:00 amRNSConfirms Sustained Helium Concentrations of 7-8%
17th Sep 20254:09 pmRNSWarrant Exercise and TVR
10th Sep 20257:00 amRNS-RPulsar European Growth Virtual Investor Conference
9th Sep 20257:00 amRNSCommencement of Plant Engineering Study
2nd Sep 20257:00 amRNSProposed Acquisition Major Minnesota Land Position
1st Sep 20257:00 amRNSQ3 2025 Financial and Operating Results
28th Aug 202511:00 amRNSReceipt of Conditional Approval - Update Fundraise
28th Aug 20257:00 amRNS-RInvestor Webinar via Investor Meet Company
26th Aug 20257:00 amRNSReports Jetstream 1 Flowing Over 1.3 M Cubic Feet
21st Aug 20257:27 amRNSPulsar Helium Announces Result of Fundraise
20th Aug 20254:57 pmRNSFundraise of up to GBP 5 Million
18th Aug 20257:00 amRNSMajor Flow Test Results Jetstream 1, Topaz Project
15th Aug 20257:00 amRNSReceipt of Non-Binding $12.5M Project Financing
24th Jun 20257:00 amRNSEngages Sproule-ERCE Pre-Feasibility Study Tunu
17th Jun 20257:00 amRNSUpdate for Jetstream Well Testing Program at Topaz
29th May 20257:00 amRNSFinancial and Operating Results Q2 2025
6th May 20257:00 amRNSResults of 2025 Annual General and Special Meeting
28th Apr 20257:00 amRNSUpdate for Well-Testing at Topaz Helium Project
24th Apr 20256:00 pmRNSPSU Share Issuance and Total Voting Rights
8th Apr 20257:00 amRNSExecution of US$4M Project Finance Facility LOC
7th Apr 20257:00 amRNSNotice of Annual General and Special Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.